Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Feasibility of 3D Therapy Thrive for Inpatients With Opioid Use Disorder

NCT06255119 is registered in ClinicalTrials.gov with 3D Therapy, LLC as lead sponsor.

NCT NCT06255119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06255119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Feasibility of 3D Therapy Thrive for Inpatients With Opioid Use Disorder
Lead sponsor
3D Therapy, LLC
Phase
Not applicable
Overall status
Completed
Start date
October 18, 2022
Completion date
December 31, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder